Publication | Closed Access

TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues

Natural Killer CellsIde AnaloguesViral HepatitisImmunologyImmune RegulationHepatitisT Cell ImmunityCd4 T Cell ResponsesImmune FunctionHumoral ImmunityImmunotherapeuticsCellular Immune ResponseMedicineViral Immunity